XDx’s AlloMap® Considered ‘Medically Necessary’ by Aetna Inc. for Heart Transplant Recipients
AlloMapadded to Aetna’s clinical policy bulletin for heart transplantation
“We are pleased by Aetna’s decision and the resulting opportunity to expand our product and services offering to more patients,” said Pierre Cassigneul, president and CEO of XDx. “Recognition of AlloMap’s benefit for eligible heart transplant recipients by one of the leading providers of health care in
Following heart transplants, patients typically undergo multiple endomyocardial biopsies, a highly invasive method of monitoring for post-transplant rejection. AlloMap is a simple, non-invasive blood test that can help physicians evaluate whether a patient is at low risk for heart transplant rejection. There are about 2,100 heart transplants in
About AlloMap® Molecular Expression Technology
AlloMap Molecular Expression Testing is a non-invasive gene expression test used to aid in the identification of heart transplant recipients with stable allograft function who have a low probability of moderate/severe acute cellular rejection at the time of testing in conjunction with a standard clinical assessment. AlloMap testing measures the expression levels of 20 genes from a blood sample. The combined expression of these genes is represented as an AlloMap test score. AlloMap is performed in the XDx CLIA-certified laboratory and has been commercially available since 2005. AlloMap was cleared by the
About XDx
Source:


Scotiabank reports record earnings of $1,174 million for the first quarter
ACL Services to Present at Audit Leadership Conference
Advisor News
- Survey: Most Americans still feel prosperous despite economic worries
- SEC settlement would require Tai Lopez, two others, to pay $6.8 million
- The Gen Z money paradox
- NAIFA applauds final SECURE 2.0 regulations
- What will Democrats in Congress do about healthcare and retirement?
More Advisor NewsAnnuity News
- AM Best Affirms Credit Ratings of Global Atlantic Financial Group Limited and Its Subsidiaries
- Best’s Market Segment Report: AM Best Maintains Stable Outlook on US Life/Annuity Insurance Segment
- AM Best Affirms Credit Ratings of Massachusetts Mutual Life Insurance Company and Its Subsidiaries
- Boomers want retirement protection, but their actions don’t match their mindset
- NAIC task force to address LTC riders
More Annuity NewsHealth/Employee Benefits News
- EXPLORING INSULIN COST-SHARING CAPS FOR PATIENTS WITH PRIVATE COVERAGE
- THE AMERICAN DIABETES ASSOCIATION FIGHTS TO MAINTAIN ACCESS TO HEALTH INSURANCE
- Grand jury accuses veteran of making false disability claims that defrauded VA
- States push short-term insurance as healthcare costs climb
- Study Findings on Managed Care Are Outlined in Reports from Massachusetts General Hospital (A RUC Rescue of Primary Care?): Managed Care
More Health/Employee Benefits NewsLife Insurance News
- FORMER PRINCE GEORGE'S COUNTY INSURANCE AGENT SENTENCED FOR FELONY INSURANCE THEFT SCHEME
- AM Best Affirms Credit Ratings of Ameriprise Financial, Inc. and Its Subsidiaries
- AM Best Takes Various Credit Rating Actions on Certain Subsidiaries of Auto-Owners Insurance Group
- AM Best Affirms Credit Ratings of Global Atlantic Financial Group Limited and Its Subsidiaries
- AM Best Downgrades Credit Ratings of CICA Life Insurance Company of America
More Life Insurance News